Influence of proton pump inhibitors on the incidence and clinical course of oesophageal fistula following catheter ablation for atrial fibrillation: a subanalysis of the POTTER-AF study

By afschroeder • October 25, 2025

Beiert T, Knappe V, Zietzer A, Schmidt V, Pürerfellner H, Sommer P, Sohns C, Veltmann C, Steven D, Chun KJ, Maury P, Gandjbakhch E, Laredo M, Willems S, Borlich M, Füting A, Spittler R, Richter S, Schade A, Kuniss M, Wunderlich C, Shin DI, Meininghaus DG, Bonsels M, Reek D, Wiegand U, Bauer A, Metzner A, Eckardt L, Krahnefeld O, Sticherling C, Kühne M, Nguyen DQ, Roten L, Linz D, van der Voort P, Mulder BA, Vijgen J, Almorad A, Guenancia C, Fauchier L, Boveda S, De Greef Y, Da Costa A, Jais P, Milhem A, Jesel L, Garcia R, Poty H, Khoueiry Z, Seitz J, Laborderie J, Mechulan A, Brigadeau F, Zhao A, Saludas Y, Piot O, Ahluwalia N, Martin CA, Chen J, Antolic B, Leventopoulos G, Özcan EE, Yorgun H, Cay S, Yalin K, Botros MS, Jędrzejczyk-Patej E, Inaba O, Okumura K, Ejima K, Khakpour H, Catanzaro JN, Reddy V, Natale A, Blessberger H, Yang B, Vogler J, Kuck KH, Merino JL, Keelani A, Heeger CH, Popescu SS, Tilz RR. Influence of proton pump inhibitors on the incidence and clinical course of oesophageal fistula following catheter ablation for atrial fibrillation: a subanalysis of the POTTER-AF study. Europace. 2025 Oct 7;27(10):euaf212. doi: 10.1093/europace/euaf212. PMID: 41133846; PMCID: PMC12550554.

Tags: atrial fibrillation, Cardiology/Epi, catheter ablation, oesophageal fistula, proton pump inhibitor, Publications

Barriers and Emerging Strategies to Bridge Gaps in Implementation of Evidence-Based Lipid-Lowering Therapies

Marnell CS, Koenig W, Bittner V, Watson KE, Muntner P, Nordestgaard BG, Yan LL, Verbakel M, Rosenson RS. Barriers and Emerging Strategies to Bridge Gaps[...]

New 10-Year Atherosclerosis Cardiovascular Disease Risk Score for Asian and American Indian Women Service Members

Jeon-Slaughter H, Whyne EZ, Doyle C, Chen X, Chiou SH, Tsai S, Ebrahimi R. New 10-Year Atherosclerosis Cardiovascular Disease Risk Score for Asian and American[...]

Cardiovascular disease mortality among women diagnosed with de novo metastatic breast cancer

Ramin C, Gresham G, Li J, Karlstaedt A, Hashibe M, Nikolova AP, Atkins KM. Cardiovascular disease mortality among women diagnosed with de novo metastatic breast[...]